Dabur India Ltd FSSAI labelling crackdown

Today (17 September 2026), Moneycontrol reported that the Food Safety and Standards Authority of India (FSSAI) has expanded its labelling crackdown on Dabur, ordering a statutory audit of 27 product lines. The notice, dated 19 August, covers categories such as D2C wellness and nutraceutical products, glucose powders, and some kitchen staples, and asks Dabur to submit scientific dossiers and peer‑reviewed human clinical trial data to support health and immunity claims. This follows an earlier FSSAI notice that led Dabur to modify some advertising and packaging claims. implying roughly 10–12% upside from recent levels. Kotak expects 9–10% revenue and EPS growth in FY27, driven by a recovery in operating performance, but flags portfolio transformation (including the international foods business and some legacy categories) as a medium‑term challenge.